🔎 Trials Near Me

Akèy › Maladi Crohn › Texas › Lewisville

Etid klinik pou Maladi Crohn nan Lewisville, TX

9 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Lewisville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Ap rekriteFaz 2
  • Texas Digestive Disease Consultants - Southlake /ID# 283931, Southlake · 11 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT07697456

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Ap rekriteFaz 3
  • GI Alliance - Southlake ( Site 0298), Southlake · 11 mi lwen
Tout laj · Tout sèks · Mizajou Oct 2, 2026 · NCT06651281

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Ap rekriteFaz 3
  • GI Alliance - Southlake ( Site 5109), Southlake · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06430801

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 2/3
  • GI Alliance Southlake, Southlake · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196722

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office-Site Number: 8400101, Southlake · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake-Site Number: 8400101, Southlake · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184944

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 2
  • Prime Clinical Research - Lewisville, Lewisville
Laj 18 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT06226883

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Ap rekriteFaz 4
  • Texas Digestive Disease Consultants (TDDC), Southlake, Southlake · 11 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06045754

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Ap rekriteFaz 2
  • Mirador Therapeutics Selected Site, Southlake · 11 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

Etid Maladi Crohn nan lòt vil

Lòt etid nan Lewisville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.